Abstract:It remains controversial whether papillary thyroid cancer (PTC) patients with low- to intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy (TT). We aim to identify those who might benefit from RAI treatment in PTC patients with cervical nodal metastasis after TT. Patients were divided into TT and TT+RAI groups from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2018). Overall survival (OS) and cancer-specific survival (CSS) were compared, and propensity score matching (PSM) was performed between groups. A total of 15,179 patients were enrolled, including 3,387 (22.3%) who underwent TT and 11,792 (77.7%) who received TT+RAI. The following characteristics were more likely to present in the TT+RAI group: multifocality, capsular extension, T3, N1b, and more metastatic cervical lymph nodes. RAI was associated with better OS in low- to intermediate-risk PTC patients in the multivariate Cox regression model. The subgroup analysis showed that RAI predicted better OS in patients ≥55 years, American Joint Committee on Cancer (AJCC) stage II, and capsular extension with a hazard ratio (HR) (95% CI) of 0.57 (0.45–0.72), 0.57 (0.45–0.72), and 0.68 (0.51–0.91), respectively. However, RAI failed to improve the prognoses of patients with age <55 years, AJCC stage I, PTC ≤1 cm, and capsular invasion. In the PSM cohort with 3,385 paired patients, TT+RAI treatment predicted better OS compared with TT alone. In addition, TT+RAI predicted better OS in patients with metastatic cervical lymph nodes ≥2, multifocality, extracapsular extension, and American Thyroid Association (ATA) intermediate risk. In conclusion, RAI was associated with better OS in low- to intermediate-risk PTC patients with age ≥55 years, multifocality, extrathyroidal extension, and ATA intermediate risk. However, the survival benefit from RAI may be limited in patients with AJCC stage I, PTC ≤1 cm, unifocality, capsular invasion, and ATA low-risk diseases; these patients even showed pathological cervical lymph node metastasis.

Predictors of distant metastatic recurrence in intermediate‐risk papillary thyroid carcinoma

Evaluation of Clinical Risk Factors for Predicting Insidious Right Central and Posterior Right Recurrent Laryngeal Nerve Lymph Node Metastasis in Papillary Thyroid Microcarcinoma Patients (cn0): Experience of a Single Center.

Impact of different categories of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study.

Efficacy of postoperative radioactive iodine therapy for patients with low and intermediate risk papillary thyroid carcinoma

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer

Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan

Nomogram-Based New Recurrence Predicting System in Early-Stage Papillary Thyroid Cancer

The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up

Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer

Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma

Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications.

A high Ki‐67 labeling index and high thyroglobulin doubling rate are significant predictors of excision‐site recurrence of papillary thyroid carcinoma following airway resection for locally curative surgery

Risk factors associated with lymph node metastasis in papillary thyroid cancer: a retrospective analysis based on 2,428 cases

A Retrospective Study with a Propensity Score-Matched Analysis

The U-Shaped Association between Age at Diagnosis and Recurrence in Patients with Papillary Thyroid Carcinoma: A Retrospective Single-Institution Cohort Study

The outcomes and prognostic factors in patients after reoperation of persistent/recurrent papillary thyroid carcinoma

Patient Age Is Significantly Related to Distant Metastasis of Papillary Thyroid Microcarcinoma

Association of Lymph Nodes Positive Rate with the Risk of Recurrence in Patients with Stage T1 Papillary Thyroid Cancer

Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis.

Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients